Insider · CIK 0001418307
Sean Whelan
Files at ZOMDF (Zomedica Corp.). First filing -, latest -.
In brief
Sean Whelan files SEC Form 4 as director at ZOMDF (Zomedica Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sean Whelan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | ZOMDF Zomedica Corp. | AGrant or award Stock Appreciation Rightderivative | +1,975,033 | $0.00 | $0 | 1,975,033 | Nov 18, 2025 |
| Nov 11, 2024 | ZOMDF Zomedica Corp. | AGrant or award Stoock Appreciation Rightsderivative | +1,975,033 | $0.00 | $0 | 1,975,033 | Nov 13, 2024 |
Questions about Sean Whelan
Answered from the filings on this page, as of the latest one.
Is Sean Whelan buying or selling?
Sean Whelan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sean Whelan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sean Whelan has 0.
Where does Sean Whelan file Form 4?
Sean Whelan has filed Form 4 at ZOMDF (Zomedica Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.